Recruiting studies: Long Acting Injectable Cabotegravir For Prep

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Phase 3 · 1 location(s) · Evandro Chagas National Institute of Infectious Disease · NCT05515770 The TAIL-PrEP Study
NA · 1 location(s) · Columbia University · NCT06868641 PathToScale: The PERSIST Trial
NA · 1 location(s) · Georgetown University · NCT07221747 Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
Phase 4 · 2 location(s) · Massachusetts General Hospital · NCT07199335 BetterInfo on Women's PrEP Choices and Outcomes in Malawi
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT07579754 PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-expos
Phase N/A · 1 location(s) · Desmond Tutu HIV Foundation · NCT06807736

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.